Table 1 Baseline characteristics of the study population on admission.
From: Analysis of SARS-CoV-2 vertical transmission during pregnancy
Characteristics at delivery | Total study population (n = 31) |
|---|---|
Maternal baseline characteristics | |
Maternal age, years, median (range) | 30 (15–45) |
RT-PCR assay of a maternal nasopharyngeal swab | |
Positive, n (%) | 30 (97) |
Negative, n (%) | 1a (3) |
Prepregnancy BMI, kg/m2, median (range) | 23 (17–37) |
Known sick contact, n (%) | 10 (32) |
Smoking habit, n (%) | 0 |
Ethnicity, Caucasian, n (%) | 21 (68) |
Chronic comorbidity, n (%) | 11 (35) |
Parity, nulliparous n (%) | 14 (45) |
Flu vaccination in pregnancy, n (%) | 8 (26) |
Ante-partum therapy | |
Antibiotic, n (%) | 10 (32) |
Lopinavir/Ritonavir, n (%) | 8 (26) |
Hydroxychloroquine, n (%) | 13 (42) |
Oxygen support without ICU admission, n (%) | 4 (13) |
Positive chest X-ray, n (%) | 14 (45) |
Severe case, n (%) | 4 (13) |
Admission to ICU, n (%) | 1 (3) |
